Citation: G. Lambert et M. Krempf, Identification of ABCG5 and ABCG8 important in the regulation of dietary cholesterol absorption, M S-MED SCI, 17(6-7), 2001, pp. 814-815
Authors:
Nazih, H
Nazih-Sanderson, F
Krempf, M
Huvelin, JM
Mercier, S
Bard, JM
Citation: H. Nazih et al., Butyrate stimulates ApoA-IV-containing lipoprotein secretion in differentiated Caco-2 cells: Role in cholesterol efflux, J CELL BIOC, 83(2), 2001, pp. 230-238
Authors:
Ducimetiere, P
Signeyrole, D
Giral, P
Hoog-Labouret, N
Amarenco, P
Chanu, B
Chauvenet, M
Coletti, M
Dallongeville, J
Durlach, V
Kawka, G
Krempf, M
Leroux, G
Mlika-Cabanne, N
Monnier, L
Paillard, F
Rostoker, G
Sicard, D
Verny, C
Voiriot, P
Acquart, B
Alquier, G
Ankri, J
Badoc, G
Basdevant, A
Belmin, J
Berthezene, F
Beucler, I
Blanc, F
Broustet, JP
Bruckert, E
Brun, JM
Castaigne, A
Charpentier, JM
Andre, MC
Cogneau, J
Demeaux, JL
Denolle, T
Desson, JF
Drahi, E
Drouin, P
Dumel, F
Emmerich, J
Farnier, M
Fontbonne, A
Forette, B
Gambert, P
Gautier, JC
Guillausseau, PJ
Hommel, M
Janowski, M
Le Goaziou, MF
Lievre, M
Le Quere, M
Leys, D
Marechaud, R
Mas, JL
Menard, J
Michel, JM
Mounier-Vehier, F
Mottier, D
Passa, P
Pinel, JF
Puel, J
Raccah, D
Renou, P
Ribier, A
Schlienger, JL
Thomas, D
Vallee, JP
Veyssier-Belot, C
Bouvenot, G
Abadie, E
Alexandre, JM
Belorgey-Bismut, C
Bergmann, JF
Camelli, B
Caulin, C
Costagliola, D
Denis, C
Dupuis, B
Fleurette, F
Guillevin, L
Hoog-Labouret, N
Paintaud, G
Rauss, A
Poynard, T
Rostoker, G
Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
Authors:
Bach-Ngohou, K
Nazih, H
Nazih-Sanderson, F
Zair, Y
Le Carrer, D
Krempf, M
Bard, JM
Citation: K. Bach-ngohou et al., Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential antiinflammatory role of apoE in vivo, INT J OBES, 25(12), 2001, pp. 1752-1758
Authors:
Frenais, R
Maugeais, C
Ouguerram, K
Zair, Y
Bard, JM
Charbonnel, B
Magot, T
Krempf, M
Citation: R. Frenais et al., Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia, METABOLISM, 50(6), 2001, pp. 635-639
Authors:
Bach-Ngohou, K
Giraud, F
Krempf, M
Bard, JM
Citation: K. Bach-ngohou et al., Influence of remnant accumulation markers on plasma concentrations of two lipoprotein(a) subspecies (containing or free of apoE), METABOLISM, 50(3), 2001, pp. 277-282
Authors:
Frenais, R
Nazih, H
Ouguerram, K
Maugeais, C
Zair, Y
Bard, JM
Charbonnel, B
Magot, T
Krempf, M
Citation: R. Frenais et al., In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus, J CLIN END, 86(5), 2001, pp. 1962-1967
Authors:
Maugeais, C
Ouguerram, K
Frenais, R
Maugere, P
Charbonnel, B
Magot, T
Krempf, M
Citation: C. Maugeais et al., Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia, J CLIN END, 86(4), 2001, pp. 1679-1686
Authors:
Frenais, R
Ouguerram, K
Maugeais, C
Mahot, P
Charbonnel, B
Magot, T
Krempf, M
Citation: R. Frenais et al., Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus, ATHEROSCLER, 157(1), 2001, pp. 131-135
Authors:
Krempf, M
Rohmer, V
Farnier, M
Issa-Sayegh, M
Corda, C
Sirugue, I
Gerlinger, C
Masseyeff-Elbaz, MF
Citation: M. Krempf et al., Efficacy and safety of micronised fenofibrate in a randomised double-blindstudy comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia, DIABETE MET, 26(3), 2000, pp. 184-191
Authors:
Rabes, JP
Varret, M
Devillers, M
Aegerter, P
Villeger, L
Krempf, M
Junien, C
Boileau, C
Citation: Jp. Rabes et al., R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia, ART THROM V, 20(10), 2000, pp. E76-E82
Authors:
Saint-Jore, B
Varret, M
Dachet, C
Rabes, JP
Devillers, M
Erlich, D
Blanchard, P
Krempf, M
Mathe, D
Chanu, B
Jacotot, B
Farnier, M
Bonaiti-Pellie, C
Junien, C
Boileau, C
Citation: B. Saint-jore et al., Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects, EUR J HUM G, 8(8), 2000, pp. 621-630
Authors:
Boutoille, D
Leautez, S
Maulaz, D
Krempf, M
Raffi, F
Citation: D. Boutoille et al., Skin bone and joint bacterial infections in the diabetic foot: Epidemiology and pathophysiology, PRESSE MED, 29(7), 2000, pp. 389-392
Authors:
Noah, L
Krempf, M
Lecannu, G
Maugere, P
Champ, M
Citation: L. Noah et al., Bioavailability of starch and postprandial changes in splanchnic glucose metabolism in pigs, AM J P-ENDO, 278(2), 2000, pp. E181-E188
Authors:
Sjostrom, L
Rissanen, A
Andersen, T
Boldrin, M
Golay, A
Koppeschaar, H
Krempf, M
Citation: L. Sjostrom et al., Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients, TERAPEVT AR, 72(8), 2000, pp. 50-54
Authors:
Colombel, A
Murat, A
Krempf, M
Kuchly-Anton, B
Charbonnel, B
Citation: A. Colombel et al., Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections, DIABET MED, 16(4), 1999, pp. 319-324
Authors:
Diraison, F
Large, V
Maugeais, C
Krempf, M
Beylot, M
Citation: F. Diraison et al., Noninvasive tracing of human liver metabolism: comparison of phenylacetateand apoB-100 to sample glutamine, AM J P-ENDO, 40(3), 1999, pp. E529-E536